SCHEMBL534639

SCHEMBL534639

c1ccc(Cc2ccc(Sc3ccc(Cc4ccccc4)cc3)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.63
SLC6A4 P31645 1/20 0.50
LTA4H P09960 4/20 0.48
IDH1 O75874 1/20 0.46
HTR2C P28335 1/20 0.45
HTR6 P50406 1/20 0.45
LMNA P02545 2/20 0.45
PLA2G10 O15496 1/20 0.45
PLA2G2A P14555 1/20 0.45
NPSR1 Q6W5P4 2/20 0.44
PRNP P04156 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PPARG P37231 1/20 0.44
HTT P42858 1/20 0.44
NCOA2 Q15596 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
SLC22A2 O15244 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10707308 0.97 CALM1 (0.60) CALM1SLC6A4LTA4HIDH1HTR2C
SCHEMBL4116259 0.93 CALM1 (0.55) CALM1SLC6A4LTA4HIDH1HTR2C
SCHEMBL13531403 0.91 CALM1 (0.52) CALM1SLC6A4LTA4HIDH1HTR2C
SCHEMBL21888595 0.91 CALM1 (0.52) CALM1SLC6A4LTA4HIDH1HTR2C
SCHEMBL99594 0.89 SMN1; SMN2 (0.55) CALM1SLC6A4LTA4HLMNANPSR1
SCHEMBL11590694 0.89 NR1H2 (0.58) CALM1SLC6A4IDH1LMNAPLA2G10
SCHEMBL28981220 0.84 ESR1 (0.58) CALM1SLC6A4IDH1LMNANPSR1
SCHEMBL28535566 0.84 MAOB (0.54) SLC6A4HTR2CHTR6MAOAMAOB
SCHEMBL946830 0.84 CALM1 (0.63) CALM1LTA4HIDH1LMNAPLA2G10
SCHEMBL972712 0.83 CALM1 (0.92) CALM1LTA4HIDH1LMNAPLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113707933-B Preparation method of solid electrolyte nano dispersion liquid of lithium ion battery and solid electrolyte nano dispersion liquid 浙江蓝珧新材料科技有限公司 2024-04-09 CN claimed
CN-115651017-A Method for selectively preparing benzyl or alkyl phosphine oxide compound based on benzyl thioether derivative 中南大学 2023-01-31 CN claimed
CN-113707933-A Preparation method of solid electrolyte nano dispersion liquid of lithium ion battery and solid electrolyte nano dispersion liquid 北京卫蓝新能源科技有限公司 2021-11-26 CN claimed
CN-114641552-B Heat transfer fluid for cryocooler applications 科慕埃弗西有限公司 2025-03-07 CN disclosed
CN-112805824-B Thermosetting resin film and sheet for forming first protective film 琳得科株式会社 2025-01-07 CN disclosed
CN-114599755-B Sheet for semiconductor device manufacture, method for manufacturing the same, and method for manufacturing semiconductor chip with film-like adhesive 琳得科株式会社 2024-12-31 CN disclosed
CN-119141993-A Film for forming protective film and composite sheet for forming protective film 琳得科株式会社 2024-12-17 CN disclosed
CN-112533934-B Polyoxometallate compounds exhibiting bright emissions and methods of making same 纳米2D材料有限公司 2024-07-19 CN disclosed
CN-113707933-B Preparation method of solid electrolyte nano dispersion liquid of lithium ion battery and solid electrolyte nano dispersion liquid 浙江蓝珧新材料科技有限公司 2024-04-09 CN disclosed
WO-2024063129-A1 ADHESIVE SHEET AND PEELING METHOD リンテック株式会社 2024-03-28 WO disclosed
WO-2024063128-A1 LAMINATE リンテック株式会社 2024-03-28 WO disclosed
EP-1640363-B1 PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING SAN APRO LTD (JP) 2008-01-16 EP disclosed
EP-1806337-A1 METHOD FOR PRODUCING THIOETHER COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-07-11 EP disclosed
US-20060247401-A1 Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing SAN-APRO LIMITED (JP) 2006-11-02 US disclosed
US-7060858-B2 Method for manufacturing sulfonium salts SAN-APRO LIMITED (JP) 2006-06-13 US disclosed
EP-1640363-A1 PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING San-Apro Limited (JP) 2006-03-29 EP disclosed
US-20040030158-A1 Method for manufacturing sulfonium salts SAN-APRO LIMITED (JP) 2004-02-12 US disclosed
EP-1350789-A1 PROCESS FOR PRODUCING SULFONIUM SALT San-Apro Limited (JP) 2003-10-08 EP disclosed
US-5342903-A Process for the preparation of adducts of epoxides and alcohols CIBA-GEIGY CORPORATION (US) 1994-08-30 US disclosed
US-5149767-A Epoxy compound or resin and polyisocyanate; high heat distortion point CIBA-GEIGY CORPORATION (US) 1992-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247401-A1 Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing RPS6, SPIN4, SRM CALM1 3744/4885SLC6A4 443/4885LTA4H 2538/4885
US-20040030158-A1 Method for manufacturing sulfonium salts MLX, STS, SULT1A1 CALM1 4319/4885SLC6A4 519/4885LTA4H 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.